1Pathology Division, National Cancer Research Institute.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Accurate classification of malignant lymphomas, including Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL), is crucial for effective treatment. Current non-Hodgkin's lymphoma classifications need improvement to integrate new scientific understanding for better clinical application.
Area of Science:
Context:
Purpose:
Summary:
Impact: